Services
We provide a unique combination of skillsets, infrastructure, and distribution that allow entrepreneurial health tech innovations to scale:
01 →
Curate…
promising exponential health technologies based on thorough technology, corporate & scientific due diligence. GHPX considers deal-flow from across the Middle East, Sub-Saharan Africa, Europe, South and South-East Asia and North America.
← 02
Infuse…
companies with capital in partnership with impact funds. GHPX maintains partnerships with early-stage tech investors. Provides fundraising and capitalization strategies, corporate development, and investor outreach through the identification of potential strategic partners through our capital market networks. Our team specializes in narrative development communications strategies for capital markets and commercial targets.
03 →
Enhance
corporate leadership & product with in-house GHPX capabilities including digital health, telemedicine, life sciences, regulatory process, health science research design and implementation, epidemiology, non-communicable diseases (mental health, CVD, Cancer, Diabetes), infectious diseases & pandemics and public health and policy. Our team has extensive experience with exponential technologies including AR / VR / XR, Metaverse, spatial computing, artificial intelligence, web 3.0, Medical Internet of Things.
← 04
Scale…
through GHPX global distribution networks
05 →
Quantify…
the impacts of health tech involving measuring the effectiveness of new technologies and innovations in improving health outcomes. By using data-driven analysis and evaluation we aid in providing analytics — health report cards on the impact of health tech based on various metrics such as patient satisfaction, clinical outcomes, and financial performance. This information can then be used to optimize and refine these technologies and to make informed decisions about which ones to adopt and secure investment.
